9-134642252-CGCTGCTGCT-CGCTGCT
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_000093.5(COL5A1):c.82_84del(p.Leu28del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00323 in 1,249,090 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000047 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 0 hom. )
Consequence
COL5A1
NM_000093.5 inframe_deletion
NM_000093.5 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.96
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 9-134642252-CGCT-C is Benign according to our data. Variant chr9-134642252-CGCT-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 570337.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}. Variant chr9-134642252-CGCT-C is described in Lovd as [Likely_benign]. Variant chr9-134642252-CGCT-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.00366 (4023/1099178) while in subpopulation SAS AF= 0.0081 (282/34820). AF 95% confidence interval is 0.00732. There are 0 homozygotes in gnomad4_exome. There are 2114 alleles in male gnomad4_exome subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A1 | NM_000093.5 | c.82_84del | p.Leu28del | inframe_deletion | 1/66 | ENST00000371817.8 | NP_000084.3 | |
COL5A1 | NM_001278074.1 | c.82_84del | p.Leu28del | inframe_deletion | 1/66 | NP_001265003.1 | ||
COL5A1 | XM_017014266.3 | c.82_84del | p.Leu28del | inframe_deletion | 1/65 | XP_016869755.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL5A1 | ENST00000371817.8 | c.82_84del | p.Leu28del | inframe_deletion | 1/66 | 1 | NM_000093.5 | ENSP00000360882 | P4 | |
COL5A1 | ENST00000371820.4 | c.82_84del | p.Leu28del | inframe_deletion | 1/66 | 2 | ENSP00000360885 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000467 AC: 7AN: 149912Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
149912
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0102 AC: 450AN: 43910Hom.: 0 AF XY: 0.00967 AC XY: 254AN XY: 26278
GnomAD3 exomes
AF:
AC:
450
AN:
43910
Hom.:
AF XY:
AC XY:
254
AN XY:
26278
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00366 AC: 4023AN: 1099178Hom.: 0 AF XY: 0.00397 AC XY: 2114AN XY: 532712
GnomAD4 exome
AF:
AC:
4023
AN:
1099178
Hom.:
AF XY:
AC XY:
2114
AN XY:
532712
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000467 AC: 7AN: 149912Hom.: 0 Cov.: 32 AF XY: 0.0000684 AC XY: 5AN XY: 73116
GnomAD4 genome
AF:
AC:
7
AN:
149912
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
73116
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 28, 2019 | - - |
Ehlers-Danlos syndrome, classic type, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 570337). This variant has not been reported in the literature in individuals affected with COL5A1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant, c.82_84del, results in the deletion of 1 amino acid(s) of the COL5A1 protein (p.Leu28del), but otherwise preserves the integrity of the reading frame. - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at